peter attia glp 1 398 ‒ AMA #86: GLP-1 RAs and muscle loss: new data, better questions, and how to preserve muscle during weight loss Any insights around Metformin or
Description
Purity Meets Potency
GLP-1 medications have shown impressive results, and one in eight Americans has already tried them
Glucagon-like peptide-1 (GLP-1) receptor agonists have been used extensively in the clinic and have an established safety profile in cardiovascular disease settings
Recently, the Food and Drug Administration officially approved semaglutide for the treatment of metabolic dysfunction-associated steatohepatitis in adults with moderate-to-advanced fibrosis
But how do they compare for the unique needs of GLP-1 users
